Antibiotic-Impregnated Grafts for Aortic Reconstruction

Quinones-Baldrich, 1991, Long-term results following surgical management of aortic graft infection, Arch Surg, 126, 507, 10.1001/archsurg.1991.01410280111018 Reilly, 1984, Late results following surgical management of vascular graft infection, J Vasc Surg, 1, 36, 10.1016/0741-5214(84)90182-4 O'Hara, 1986, Surgical management of infected abdominal aortic grafts: review of a 25-year experience, J Vasc Surg, 3, 725, 10.1016/0741-5214(86)90036-4 Walker, 1987, The management of aortoduodenal fistula by in situ replacement of the infected abdominal aortic graft, Ann Surg, 205, 727, 10.1097/00000658-198706000-00015 Bailey, 1987, Successful treatment of an infected vascular graft with gentamicin beads, Eur J Vasc Surg, 1, 143, 10.1016/S0950-821X(87)80013-0 Benaerts, 1999, Gentamicin beads in vascular surgery: long-term results of implantation, Cardiovasc Surg, 7, 447, 10.1016/S0967-2109(99)00015-0 Jorgensen, 1991, Clinical and pharmacokinetic evaluation of gentamycin containing collagen in groin wound infections after vascular reconstruction, Eur J Vasc Surg, 5, 87, 10.1016/S0950-821X(05)80933-8 Kwaan, 1981, Successful management of prosthetic graft infection with continuous povidone-iodine irrigation, Arch Surg, 116, 716, 10.1001/archsurg.1981.01380170188033 Popovsky, 1980, Infected prosthetic grafts, Arch Surg, 115, 203, 10.1001/archsurg.1980.01380020069016 Morris, 1994, Antibiotic irrigation and conservative surgery for major aortic graft infection, J Vasc Surg, 20, 88, 10.1016/0741-5214(94)90179-1 Harvey, 1981, The noncovalent bonding of antibiotics to a polytetrafluoroethylene-benzalkonium graft, Ann Surg, 194, 642, 10.1097/00000658-198111000-00015 Greco, 1982, Prevention of vascular prosthetic infection by a benzalkonium-oxacillin bonded polytetrafluoroethylene graft, Surg Gynecol Obstet, 155, 28 Greco, 1982, The role of antibiotic bonding in the prevention of vascular prosthetic infections, Ann Surg, 195, 168, 10.1097/00000658-198202000-00008 Greco, 1984, The biochemical bonding of cefoxitin to a microporous polytetrafluoroethylene surface, J Surg Res, 36, 237, 10.1016/0022-4804(84)90093-3 Sobinsky, 1986, Antibiotic binding to polytetrafluoroethylene via glucosaminoglycan-keratin luminal coating, Surgery, 100, 629 Shue, 1988, Prevention of vascular prosthetic infection with an antibiotic-bonded Dacron graft, J Vasc Surg, 8, 600, 10.1016/0741-5214(88)90311-4 Harvey, 1984, Noncovalent bonding of penicillin and cefazolin to Dacron, Am J Surg, 147, 205, 10.1016/0002-9610(84)90089-8 Cooley, 1981, A method of preparing woven Dacron aortic grafts to prevent interstitial hemorrhage, Cardiovasc Dis, 8, 48 Powell, 1983, A passive system using rifampin to create an infection-resistant vascular prosthesis, Surgery, 94, 765 Moore, 1981, Development of an infection-resistant vascular prosthesis, Arch Surg, 116, 1403, 10.1001/archsurg.1981.01380230027004 Quinones-Baldrich, 1986, Development of a “leak-proof,” knitted Dacron vascular prosthesis, J Vasc Surg, 3, 895, 10.1016/0741-5214(86)90157-6 Krajicek, 1969, Infection-resistant synthetic vascular substitutes, J Cardiovasc Surg (Torino), 10, 453 Wakefield, 1987, Treatment of established prosthetic vascular graft infection with antibiotics preferentially concentrated in leukocytes, Surgery, 102, 8 Widmer, 1990, Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections, J Infect Dis, 162, 96, 10.1093/infdis/162.1.96 McDougal, 1986, Rifampin protection against experimental graft sepsis, J Vasc Surg, 4, 5, 10.1016/0741-5214(86)90315-0 Chervu, 1991, Efficacy and duration of antistaphylococcal activity comparing three antibiotics bonded to Dacron vascular grafts with a collagen release system, J Vasc Surg, 13, 897, 10.1016/0741-5214(91)90057-2 Chervu, 1991, Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system, J Vasc Surg, 14, 521, 10.1016/0741-5214(91)90246-Q Colburn, 1992, Use of an antibiotic-bonded graft for in situ reconstruction after prosthetic graft infections, J Vasc Surg, 16, 651, 10.1016/0741-5214(92)90172-5 Drury, 1987, Experimental and clinical experience with a gelatin impregnated Dacron prosthesis, Ann Vasc Surg, 1, 542, 10.1016/S0890-5096(06)61437-4 Strachan, 1991, The clinical use of an antibiotic-bonded graft, Eur J Vasc Surg, 5, 627, 10.1016/S0950-821X(05)80896-5 Avramovic, 1992, Prevention of prosthetic vascular graft infection by rifampicin impregnation of a protein-sealed Dacron graft in combination with parenteral cephalosporin, J Cardiovasc Surg (Torino), 33, 70 Goeau-Brissonniere, 1991, Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft, Ann Vasc Surg, 5, 408, 10.1007/BF02133043 Gahtan, 1995, Antistaphylococcal activity of rifampin-bonded gelatin-impregnated Dacron grafts, J Surg Res, 58, 105, 10.1006/jsre.1995.1017 Goeau-Brissonniere, 1994, Treatment of vascular graft infection by in situ replacement with a rifampin-bonded gelatin-sealed Dacron graft, J Vasc Surg, 19, 739, 10.1016/S0741-5214(94)70050-8 Goeau-Brissonniere, 2011, Rifampin-bonded vascular grafts and postoperative infections, Ann Vasc Surg, 25, 134, 10.1016/j.avsg.2010.09.002 D'Addato, 1996, Prophylaxis of graft infection with rifampicin-bonded Gelseal graft: 2-year follow-up of a prospective clinical trial, Cardiovasc Surg, 4, 200, 10.1016/0967-2109(96)82315-5 Torsello, 1993, In situ replacement of infected vascular prostheses with rifampin-soaked vascular grafts: early results, J Vasc Surg, 17, 768, 10.1016/0741-5214(93)90124-5 Hayes, 1999, In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998), J Vasc Surg, 30, 92, 10.1016/S0741-5214(99)70180-1 Young, 1999, The results of in situ prosthetic replacement for infected aortic grafts, Am J Surg, 178, 136, 10.1016/S0002-9610(99)00146-4 Oderich, 2001, Infected aortic aneurysms: aggressive presentation, complicated early outcome, but durable results, J Vasc Surg, 34, 900, 10.1067/mva.2001.118084 Bandyk, 2001, Use of rifampin-soaked gelatin-sealed polyester grafts for in situ treatment of primary aortic and vascular prosthetic infections, J Surg Res, 95, 44, 10.1006/jsre.2000.6035 Oderich, 2011, In situ rifampin-soaked grafts with omental coverage and antibiotic suppression are durable with low reinfection rates in patients with aortic graft enteric erosion or fistula, J Vasc Surg, 53, 99, 10.1016/j.jvs.2010.08.018 O'Connor, 2006, A systematic review and meta-analysis of treatments for aortic graft infection, J Vasc Surg, 44, 38, 10.1016/j.jvs.2006.02.053 Koshiko, 2002, Limitations in the use of rifampicin-gelatin grafts against virulent organisms, J Vasc Surg, 35, 779, 10.1067/mva.2002.121850 Schmacht, 2005, Graft infectivity of rifampin and silver-bonded polyester grafts to MRSA contamination, Vasc Endovascular Surg, 39, 411, 10.1177/153857440503900505 Schneider, 2008, Efficacy of collagen silver-coated polyester and rifampin-soaked vascular grafts to resist infection from MRSA and Escherichia coli in a dog model, Ann Vasc Surg, 22, 815, 10.1016/j.avsg.2008.06.011